Ideagen PLC Exercise of Options and Total Voting Rights (6181L)
13 Septiembre 2021 - 10:50AM
UK Regulatory
TIDMIDEA
RNS Number : 6181L
Ideagen PLC
13 September 2021
Ideagen PLC
("Ideagen," "the Company" or the "Group")
Exercise of Options and Total Voting Rights
Ideagen PLC (AIM: IDEA), a leading supplier of Information
Management Software to highly regulated industries, announces that,
following the exercise of options by current and former employees
of the Company, it has issued a total of 255,000 new ordinary
shares of 1 penny each in the capital of the Company ("Ordinary
Shares").
Application has been made to the London Stock Exchange for the
255,000 new Ordinary Shares to be admitted to trading on AIM
("Admission") and it is expected that Admission will become
effective and trading will commence at 8.00 a.m. on 20 September
2021.
Following the exercise of options, the total number of Ordinary
Shares in issue will be 254,910,400 and the total number of voting
rights will therefore be 254,910,400. This figure may be used by
shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest in, or
a change to their interest in, the share capital of the Company
under the FCA's Disclosure and Transparency Rules.
Enquiries:
Ideagen plc 01629 699 100
Ben Dorks, Chief Executive Officer
Emma Hayes, Chief Financial Officer
finnCap Limited 020 7220 0500
Henrik Persson/James Thompson
(Nomad)
Alice Lane (ECM)
Canaccord Genuity 020 7523 8000
Simon Bridges
Richard Andrews
FTI Consulting 020 3727 1000
Jamie Ricketts ideagen@fticonsulting.com
Dwight Burden
Valerija Cymbal
About Ideagen plc
Ideagen is a UK-headquartered, global technology company quoted
on the London Stock Exchange AIM market (Ticker: IDEA.L).
A global supplier of regulatory and compliance solutions,
Ideagen provides a common software platform and an integrated
risk-based approach to meet multi-industry standards, enabling
compliance with relevant laws, policies, and regulations.
The Group provides software and services to organisations
operating within highly regulated industries such as life sciences,
healthcare, banking and finance, insurance, aviation, and aerospace
and defence, with its main operational premises spread throughout
the UK, EU, US, Middle East and SE Asia.
Currently, over 6,000 organisations use Ideagen's products
including nine of the top 10 UK accounting firms, all of the top
aerospace and defence companies and 75% of the world's leading
pharmaceutical firms.
Ideagen's diverse and varied customer base includes many
well-known, global brands such as British Airways, Aggreko, BAE,
Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank,
Meggitt, Heineken, Johnson Matthey, Haeco Group and European
Central Bank. As well as this, Ideagen counts 250 hospitals across
the UK and US amongst its client base. For further information
please visit www.ideagen.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IOEFLFSEAAIVLIL
(END) Dow Jones Newswires
September 13, 2021 11:50 ET (15:50 GMT)
Ideagen (LSE:IDEA)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Ideagen (LSE:IDEA)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024